Clinical Trials Logo

Clinical Trial Summary

This is a post-market, prospective, randomized clinical investigation to evaluate the performance of the nanOss Cervical Interbody Fusion (IBF) device with nanOss Bioactive Bone Void Filler for the treatment of cervical disc disease. A secondary objective is to compare the performance of the nanOss Cervical IBF Device and nanOss Bioactive Bone Void Filler with the performance of the C-Plus PEEK IBF Device with autograft. This study will enroll 40 patients at one (1) site. After subjects have signed an informed consent, they will be randomly assigned to either the nanOss Cervical IBF device arm or the C-Plus PEEK IBF Device. Patients will complete the preoperative visit and examinations. Patients will be evaluated at discharge, six (6) weeks, three (3) months, six (6) months, and twelve (12) months. Patients will be evaluated at twenty-four (24) months post-operatively if they have not demonstrated fusion at the 12 month time point.


Clinical Trial Description

The nanOss Cervical Interbody Fusion Device is CE-marked for single level intervertebral body fusion from C3 to T1 for the treatment of cervical disc disease. The nanOss IBF device is designed to be used as one device per level, with graft material and supplemental fixation.

nanOss BABone Void Filler is a resorbable porous calcium phosphate bone void filler for use as a bone graft substitute or bone void filler. It is CE marked for use as a bone void filler in the spine, and it is to be re-hydrated with Bone Marrow Aspirate (BMA) alone, or a mixture of the patient's BMA and autograft.

The C-Plus PEEK IBF Device is indicated for use in skeletally mature adults at one level in the cervical spine, from C3 to T1, for the treatment of cervical disc disease. The device is to be used in patients who have had six weeks of non-operative treatment. Autogenous bone graft is placed within the central cavity of the C-Plus PEEK IBF Device.

The SlimFuse Cervical Plate System components are titanium alloy plates and screws designed to temporarily provide resistance to flexion, extension, lateral bending and axial rotation with strength and stiffness in the cervical spine (C2-C7) in order to promote cervical fusion. The anterior approach should be used when implanting the SlimFuse Cervical Plate System.

The primary goal of this study is to evaluate the outcomes between nanOss Cervical IBF Device and C-Plus PEEK IBF Device. The primary endpoint will be objectively determined via x-rays and CT scan to assess fusion. Secondary endpoints will include subjective patient scores for neck and arm pain and quality of life along with analysis of the proportion of patients who experience a treatment failure. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02586116
Study type Interventional
Source RTI Surgical
Contact
Status Completed
Phase N/A
Start date October 2015
Completion date March 2019

See also
  Status Clinical Trial Phase
Recruiting NCT06342765 - Safety and Performance of the SpineVision Posterior Fixation Systems in Thoracolumbar Spinal Treatment
Recruiting NCT03076658 - Open Access Database of Standing Full Body Radiographs in Asymptomatic Volunteers N/A
Recruiting NCT04727385 - Intervertebral DXM Gel Injection in Adults With Painful Lumbar Degenerative Disc Disease N/A
Completed NCT04702126 - Smoking Effect on Lumbar Intervertebral Disc Degeneration
Recruiting NCT02400762 - Prospective Study of Safety and Efficacy of InQu® Bone Graft Extender in Lumbar Interbody Fusion Surgery N/A
Recruiting NCT04600544 - Russian Disc Degeneration Study
Not yet recruiting NCT04134910 - The Role of Disc Nutrition in the Etiology and Clinical Treatment of Disc Degeneration N/A
Withdrawn NCT03908203 - Minimally Invasive Surgery Techniques for One-level Degenerative Lumbar Deformities Correction N/A
Recruiting NCT01989481 - Predicting the Outcome of Total Knee Arthroplasty and Spinal Surgeon N/A
Active, not recruiting NCT04759105 - Efficacy of Intradiscal Injection of Autologous BM-MSC in Worker Patients Affected by Chronic LBP Due to Multilevel IDD Phase 2
Recruiting NCT03105167 - Cortical Bone Trajectory Screws vs. Traditional Pedicle Screws Fixation N/A
Recruiting NCT06349226 - Identification of Biomarkers and Molecular Targets Involved on Intervertebral Disc Degeneration and Discogenic Pain
Enrolling by invitation NCT05110833 - Dose Responsiveness as a Measure of Clinical Effectiveness During Neuromonitored Spine Surgery
Recruiting NCT05066334 - Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD Phase 2
Terminated NCT02381067 - A Prospective Study of NuCel® in Cervical Spine Fusion N/A
Completed NCT01944345 - Patient Registry to Observe Outcomes Following Implantation of the VariLift Interbody Fusion Device N/A
Recruiting NCT05997121 - Safety and Performance of the Hexanium TLIF System in the Treatment of Degenerative Disc Disease
Active, not recruiting NCT06155409 - Safety and Performance of the SPINEVISION Hexanium ACIF in the Treatment of Cervical Spine Degenerative Disc Disease
Recruiting NCT05648474 - Intraoperative Monitoring for the Lateral Lumbar Interbody Fusion Procedure
Enrolling by invitation NCT05098431 - Comparison of Three Approaches of Electrode Placement to Detect Changes in Motor Evoked Potentials During Spine Surgery N/A